DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 43476 - 43500 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID ▼ Gene Name UniProt ID
C0033578 Prostatic Neoplasms GALNT3 2591 polypeptide N-acetylgalactosaminyltransferase 3 Q14435
C1832661 ANOPHTHALMIA AND PULMONARY HYPOPLASIA GALNT3 2591 polypeptide N-acetylgalactosaminyltransferase 3 Q14435
C0477548 Other chondrocalcinosis GALNT3 2591 polypeptide N-acetylgalactosaminyltransferase 3 Q14435
C0006663 Calcinosis GALNT3 2591 polypeptide N-acetylgalactosaminyltransferase 3 Q14435
C0042769 Virus Diseases GALNT3 2591 polypeptide N-acetylgalactosaminyltransferase 3 Q14435
C0919267 ovarian neoplasm GALNT3 2591 polypeptide N-acetylgalactosaminyltransferase 3 Q14435
C0011351 Dental Enamel Hypoplasia GALNT3 2591 polypeptide N-acetylgalactosaminyltransferase 3 Q14435
C1527284 Dental Pulp Stone GALNT3 2591 polypeptide N-acetylgalactosaminyltransferase 3 Q14435
C0024121 Lung Neoplasms GALNT3 2591 polypeptide N-acetylgalactosaminyltransferase 3 Q14435
C0011847 Diabetes GALNT3 2591 polypeptide N-acetylgalactosaminyltransferase 3 Q14435
C0016978 gallbladder neoplasm GALNT3 2591 polypeptide N-acetylgalactosaminyltransferase 3 Q14435
C0342643 Autosomal recessive hypophosphatemic vitamin D refractory rickets GALNT3 2591 polypeptide N-acetylgalactosaminyltransferase 3 Q14435
C0022661 Kidney Failure, Chronic GALNT3 2591 polypeptide N-acetylgalactosaminyltransferase 3 Q14435
C0011860 Diabetes Mellitus, Non-Insulin-Dependent GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0006826 Malignant Neoplasms GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0027651 Neoplasms GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C1956346 Coronary Artery Disease GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0028754 Obesity GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0036341 Schizophrenia GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0699791 Stomach Carcinoma GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0020456 Hyperglycemia GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0017638 Glioma GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0278701 Gastric Adenocarcinoma GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0010054 Coronary Arteriosclerosis GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0023467 Leukemia, Myelocytic, Acute GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024